NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 383 filers reported holding NEKTAR THERAPEUTICS in Q2 2018. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $44,000 | -27.9% | 1,250 | 0.0% | 0.02% | -45.2% |
| Q2 2018 | $61,000 | -54.1% | 1,250 | 0.0% | 0.03% | -55.1% |
| Q1 2018 | $133,000 | +358.6% | 1,250 | -28.6% | 0.07% | +263.2% |
| Q4 2015 | $29,000 | +52.6% | 1,750 | 0.0% | 0.02% | +46.2% |
| Q3 2015 | $19,000 | -38.7% | 1,750 | -30.0% | 0.01% | -38.1% |
| Q2 2015 | $31,000 | +3.3% | 2,500 | -0.9% | 0.02% | -16.0% |
| Q1 2014 | $30,000 | +7.1% | 2,522 | +0.9% | 0.02% | 0.0% |
| Q4 2013 | $28,000 | – | 2,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 1,350,000 | $22,950,000 | 1.87% |
| MAVERICK CAPITAL LTD | 6,655,625 | $113,146,000 | 1.81% |
| Camber Capital Management LP | 2,500,000 | $42,500,000 | 1.49% |
| Bellevue Group AG | 3,866,258 | $65,726,000 | 0.75% |
| Adero Partners, LLC | 51,500 | $876,000 | 0.75% |
| Goodman Financial Corp | 108,342 | $1,842,000 | 0.64% |
| CM Management, LLC | 35,000 | $595,000 | 0.55% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 424,504 | $7,217,000 | 0.43% |
| RICE HALL JAMES & ASSOCIATES, LLC | 568,379 | $9,662,000 | 0.34% |
| Burleson & Company, LLC | 107,736 | $1,832,000 | 0.32% |